Search results
New York Times stock price target raised, maintains buy rating on financial performance By...
Investing.com· 6 days agoThis adjustment reflects the firm's positive outlook on the media company's financial performance...
New York approves Applied DNA's pharmacogenomic test By Investing.com
Investing.com· 6 days agoApplied DNA Sciences, Inc. (NASDAQ:APDN), a company specializing in PCR-based DNA technologies,...
Rezolute announces public offering of common stock By Investing.com
Investing.com· 6 days agoRezolute , Inc. (NASDAQ:RZLT), a biopharmaceutical company specializing in treatments for rare...
MBIA director Shasta Theodore sells over $118,000 in company stock By Investing.com
Investing.com· 2 days agoMBIA Inc. (NYSE:MBI) director Shasta Theodore has sold 21,405 shares of the company's common stock,...
Immunic shareholders elect directors, ratify auditor By Investing.com
Investing.com· 6 days agoImmunic, Inc. (NASDAQ:IMUX), a biopharmaceutical company specializing in the development of...
Argan subsidiary secures major LNG project in Louisiana By Investing.com
Investing.com· 6 days agoROCKVILLE, MD— Argan , Inc. (NYSE:AGX), a company specializing in construction special trade...
S&P Global director Rebecca Jacoby buys shares worth $8,970 By Investing.com
Investing.com· 2 days agoS&P Global Inc., known for its services in consumer credit reporting and collection agencies, is a ...
Sarepta shares hold steady as competitor drug fails trial By Investing.com
Investing.com· 6 days agoOn Thursday, BMO Capital maintained a positive outlook on Sarepta Therapeutics (NASDAQ:SRPT),...
Canopy Growth director Luc Mongeau sells shares worth over $37,000 By Investing.com
Investing.com· 7 days agoCanopy Growth Corp (NYSE:NASDAQ:CGC) director Luc Mongeau has sold a portion of his holdings in the ...
Cipher Mining director Grossman sells $315k worth of shares By Investing.com
Investing.com· 5 days agoCipher Mining Inc. (NASDAQ:CIFR) director Cary Grossman has sold a significant number of company...